Leos Landa1, Alexandra Sulcova, Karel Slais. 1. Masaryk University, Faculty of Medicine, Department of Pharmacology, Brno, Czech Republic. landa@med.muni.cz
Abstract
OBJECTIVES: An increased behavioural response ("behavioural sensitization") to drugs of abuse occurs after repeated treatment. In the present study the possibility of cross-sensitization existence between various cannabinoid receptor ligands--CB1 agonist methanandamide, CB2 agonist JWH 015, and CB1 antagonist AM 251 with methamphetamine was explored. METHODS: Locomotion in the open field was measured in naive mice and in those pre-treated acutely and repeatedly (for 8 days), respectively, with either vehicle or tested drugs. RESULTS: Methamphetamine produced significant sensitization to its stimulatory effect on locomotion. Methanandamide pre-treatment elicited cross-sensitization to methamphetamine effect, whereas pre-treatment with JWH 015 did not. Combined pre-treatment with methamphetamine+AM 251 suppressed sensitization to methamphetamine. CONCLUSIONS: These results suggest that the activity of the endocannabinoid system is involved in the neuronal circuitry underlying the development of sensitization to methamphetamine.
OBJECTIVES: An increased behavioural response ("behavioural sensitization") to drugs of abuse occurs after repeated treatment. In the present study the possibility of cross-sensitization existence between various cannabinoid receptor ligands--CB1 agonist methanandamide, CB2 agonist JWH 015, and CB1 antagonist AM 251 with methamphetamine was explored. METHODS: Locomotion in the open field was measured in naive mice and in those pre-treated acutely and repeatedly (for 8 days), respectively, with either vehicle or tested drugs. RESULTS:Methamphetamine produced significant sensitization to its stimulatory effect on locomotion. Methanandamide pre-treatment elicited cross-sensitization to methamphetamine effect, whereas pre-treatment with JWH 015 did not. Combined pre-treatment with methamphetamine+AM 251 suppressed sensitization to methamphetamine. CONCLUSIONS: These results suggest that the activity of the endocannabinoid system is involved in the neuronal circuitry underlying the development of sensitization to methamphetamine.
Authors: Ana Canseco-Alba; Norman Schanz; Branden Sanabria; Juan Zhao; Zhicheng Lin; Qing-Rong Liu; Emmanuel S Onaivi Journal: Behav Brain Res Date: 2018-11-30 Impact factor: 3.332
Authors: Jesse S Rodriguez; Sherin Y Boctor; Luke C Flores; Clyde F Phelix; Joe L Martinez Journal: Neurosci Lett Date: 2010-12-15 Impact factor: 3.046
Authors: Young-Hoon Sung; Paul D Carey; Dan J Stein; Helen L Ferrett; Bruce S Spottiswoode; Perry F Renshaw; Deborah A Yurgelun-Todd Journal: Behav Brain Res Date: 2013-03-04 Impact factor: 3.332
Authors: Yosef Avchalumov; Alison D Kreisler; Wulfran Trenet; Mahasweta Nayak; Brian P Head; Juan C Piña-Crespo; Chitra D Mandyam Journal: Int J Mol Sci Date: 2021-07-30 Impact factor: 6.208
Authors: Jenni Kononoff; Philippe A Melas; Marsida Kallupi; Giordano de Guglielmo; Adam Kimbrough; Maria Scherma; Paola Fadda; Denise B Kandel; Eric R Kandel; Olivier George Journal: Sci Rep Date: 2018-09-17 Impact factor: 4.379